awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37070395-9BE143E2-D221-406B-B25F-14B8C87EBBF3
Q37070395-9BE143E2-D221-406B-B25F-14B8C87EBBF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37070395-9BE143E2-D221-406B-B25F-14B8C87EBBF3
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.
P2860
Q37070395-9BE143E2-D221-406B-B25F-14B8C87EBBF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37070395-9BE143E2-D221-406B-B25F-14B8C87EBBF3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f63f487627990fd8e0403e9c7c14ac10b7a75e10
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.